| COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... Journal of the American college of cardiology 75 (23), 2950-2973, 2020 | 3355 | 2020 |
| Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention P Généreux, G Giustino, B Witzenbichler, G Weisz, TD Stuckey, ... Journal of the American College of Cardiology 66 (9), 1036-1045, 2015 | 423 | 2015 |
| Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and thrombotic or … B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... J Am Coll Cardiol 75 (23), 2950-2973, 2020 | 402 | 2020 |
| Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research B Bikdeli, MV Madhavan, A Gupta, D Jimenez, JR Burton, ... Thrombosis and haemostasis 120 (07), 1004-1024, 2020 | 287 | 2020 |
| A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions P Généreux, I Kumsars, M Lesiak, A Kini, G Fontos, T Slagboom, I Ungi, ... Journal of the American College of Cardiology 65 (6), 533-543, 2015 | 127 | 2015 |
| Mortality, length of stay, and cost implications of procedural bleeding after percutaneous interventions using large-bore catheters B Redfors, BM Watson, T McAndrew, E Palisaitis, DP Francese, M Razavi, ... JAMA cardiology 2 (7), 798-802, 2017 | 94 | 2017 |
| Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents P Généreux, B Redfors, B Witzenbichler, MP Arsenault, G Weisz, ... International journal of cardiology 231, 61-67, 2017 | 89 | 2017 |
| Global COVID-19 thrombosis collaborative group, endorsed by the ISTH, NATF, ESVM, and the IUA, supported by the ESC working group on pulmonary circulation and right ventricular … B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... J Am Coll Cardiol 75 (23), 2950-2973, 2020 | 80 | 2020 |
| Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index P Généreux, CM Campos, M Yadav, T Palmerini, A Caixeta, KE Xu, ... EuroIntervention 11 (6), 634-42, 2015 | 47 | 2015 |
| Impact of anemia on platelet reactivity and ischemic and bleeding risk: from the assessment of dual antiplatelet therapy with drug-eluting stents study G Giustino, AJ Kirtane, U Baber, P Généreux, B Witzenbichler, ... The American Journal of Cardiology 117 (12), 1877-1883, 2016 | 38 | 2016 |
| Imaging and functional testing to assess clinical and subclinical neurological events after transcatheter or surgical aortic valve replacement: a comprehensive review M Spaziano, DP Francese, MB Leon, P Généreux Journal of the American College of Cardiology 64 (18), 1950-1963, 2014 | 33 | 2014 |
| Biomarkers in aortic stenosis: a systematic review B Redfors, A Furer, BR Lindman, D Burkhoff, G Marquis-Gravel, ... Structural Heart 1 (1-2), 18-30, 2017 | 27 | 2017 |
| Dedicated bifurcation stent for the treatment of bifurcation lesions involving large side branches: outcomes from the Tryton confirmatory study P Généreux, I Kumsars, JE Schneider, M Lesiak, B Redfors, K Cornelis, ... JACC: Cardiovascular Interventions 9 (13), 1338-1346, 2016 | 27 | 2016 |
| Sulodexide versus control and the risk of thrombotic and hemorrhagic events: meta-analysis of randomized trials B Bikdeli, S Chatterjee, AJ Kirtane, SA Parikh, GM Andreozzi, NR Desai, ... Seminars in Thrombosis and Hemostasis 46 (08), 908-918, 2020 | 24 | 2020 |
| Relation between platelet count and platelet reactivity to thrombotic and bleeding risk: from the assessment of dual antiplatelet therapy with drug-eluting stents study G Giustino, AJ Kirtane, P Généreux, U Baber, B Witzenbichler, ... The American journal of cardiology 117 (11), 1703-1713, 2016 | 21 | 2016 |
| Outcomes of a dedicated stent in coronary bifurcations with large side branches: a subanalysis of the randomized TRYTON bifurcation study P Généreux, A Kini, M Lesiak, I Kumsars, G Fontos, T Slagboom, I Ungi, ... Catheterization and Cardiovascular Interventions 87 (7), 1231-1241, 2016 | 20 | 2016 |
| Global COVID-19 Thrombosis Collaborative Group. Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research B Bikdeli, MV Madhavan, A Gupta, D Jimenez, JR Burton, ... Thromb Haemost 120 (7), 1004-1024, 2020 | 19 | 2020 |
| Angiographic predictors of 2‐year stent thrombosis in patients receiving drug‐eluting stents: insights from the ADAPT‐DES study P Généreux, B Redfors, B Witzenbichler, A Maehara, M Yadav, G Weisz, ... Catheterization and Cardiovascular Interventions 89 (1), 26-35, 2017 | 19 | 2017 |
| Individual patient data pooled analysis of randomized trials of bivalirudin versus heparin in acute myocardial infarction: rationale and methodology B Bikdeli, T McAndrew, A Crowley, S Chen, G Mehdipoor, B Redfors, ... Thrombosis and haemostasis 120 (02), 348-362, 2020 | 17 | 2020 |
| Risk stratification of patients undergoing medical therapy after coronary angiography N Bettinger, T Palmerini, A Caixeta, O Dressler, C Litherland, ... European Heart Journal 37 (40), 3103-3110, 2016 | 16 | 2016 |
Gregg StoneProfessor of Medicine, Icahn School of MedicineVerified email at mountsinai.org
